| Product Name | Category | Characteristic & Application | CDMF status |
|---|---|---|---|
|
DEXOLVE™
|
Sulfobutyl-ether-beta cycodextrin
|
• Significant solubility enhancement (10 to 100,000 fold) • Improvement of chemical stability • Increased bioavailability, facilitated delivery • Reduced aggregation • Moderate irritation or reduced side-effects • Maximized patient safety, complete r
|
√
|
